BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yan J, Tsai SY, Tsai MJ. SRC-3/AIB1: transcriptional coactivator in oncogenesis. Acta Pharmacol Sin. 2006;27:387-394. [PMID: 16539836 DOI: 10.1111/j.1745-7254.2006.00315.x] [Cited by in Crossref: 59] [Cited by in F6Publishing: 64] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Wang YX, Gao JX, Wang XY, Zhang L, Liu CM. Antiproliferative effects of selective cyclooxygenase-2 inhibitor modulated by nimotuzumab in estrogen-dependent breast cancer cells. Tumour Biol 2012;33:957-66. [PMID: 22252523 DOI: 10.1007/s13277-012-0324-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
2 Kirma NB, Tekmal RR. Transgenic mouse models of hormonal mammary carcinogenesis: advantages and limitations. J Steroid Biochem Mol Biol. 2012;131:76-82. [PMID: 22119744 DOI: 10.1016/j.jsbmb.2011.11.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
3 Alkner S, Bendahl P, Grabau D, Lövgren K, Stål O, Rydén L, Fernö M. AIB1 is a predictive factor for tamoxifen response in premenopausal women. Annals of Oncology 2010;21:238-44. [DOI: 10.1093/annonc/mdp293] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
4 Russo MA, Antico Arciuch VG, Di Cristofano A. Mouse models of follicular and papillary thyroid cancer progression. Front Endocrinol (Lausanne) 2011;2:119. [PMID: 22654848 DOI: 10.3389/fendo.2011.00119] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
5 Tzelepi V, Grivas P, Kefalopoulou Z, Kalofonos H, Varakis JN, Melachrinou M, Sotiropoulou-bonikou G. Estrogen signaling in colorectal carcinoma microenvironment: expression of ERβ1, AIB-1, and TIF-2 is upregulated in cancer-associated myofibroblasts and correlates with disease progression. Virchows Arch 2009;454:389-99. [DOI: 10.1007/s00428-009-0740-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
6 Ma X, Xu L, Wang S, Cui B, Li X, Xu J, Ning G. Deletion of steroid receptor coactivator-3 gene ameliorates hepatic steatosis. J Hepatol 2011;55:445-52. [PMID: 21184786 DOI: 10.1016/j.jhep.2010.11.022] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
7 Weiner M, Skoog L, Fornander T, Nordenskjöld B, Sgroi DC, Stål O. Oestrogen receptor co-activator AIB1 is a marker of tamoxifen benefit in postmenopausal breast cancer. Ann Oncol 2013;24:1994-9. [PMID: 23670096 DOI: 10.1093/annonc/mdt159] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
8 Jin J, Wang T, Wang Y, Chen S, Li Z, Li X, Zhang J, Wang J. SRC3 expressed in BMSCs promotes growth and migration of multiple myeloma cells by regulating the expression of Cx43. Int J Oncol 2017;51:1694-704. [PMID: 29075794 DOI: 10.3892/ijo.2017.4171] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
9 He L, Zhao H, Li B, Zhang L, Liu M, Kung H, Guan X, Bian X, Zeng Y, Xie D. Overexpression of AIB1 negatively affects survival of surgically resected non-small-cell lung cancer patients. Annals of Oncology 2010;21:1675-81. [DOI: 10.1093/annonc/mdp592] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
10 Yi P, Xia W, Wu RC, Lonard DM, Hung MC, O'Malley BW. SRC-3 coactivator regulates cell resistance to cytotoxic stress via TRAF4-mediated p53 destabilization. Genes Dev 2013;27:274-87. [PMID: 23388826 DOI: 10.1101/gad.203760.112] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 3.4] [Reference Citation Analysis]
11 Zhou XE, Suino-Powell KM, Li J, He Y, Mackeigan JP, Melcher K, Yong EL, Xu HE. Identification of SRC3/AIB1 as a preferred coactivator for hormone-activated androgen receptor. J Biol Chem 2010;285:9161-71. [PMID: 20086010 DOI: 10.1074/jbc.M109.085779] [Cited by in Crossref: 63] [Cited by in F6Publishing: 28] [Article Influence: 5.3] [Reference Citation Analysis]
12 Luo F, Li W, Zhang J, Huang K, Fu J, Xie Z. Overexpression of steroid receptor coactivator-3 in bone cancers: an in vivo immunohistochemical study with tissue microarray. Pathol Res Pract 2013;209:790-6. [PMID: 24134957 DOI: 10.1016/j.prp.2013.09.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
13 Macfarlane LA, Murphy PR. MicroRNA: Biogenesis, Function and Role in Cancer. Curr Genomics. 2010;11:537-561. [PMID: 21532838 DOI: 10.2174/138920210793175895] [Cited by in Crossref: 815] [Cited by in F6Publishing: 771] [Article Influence: 74.1] [Reference Citation Analysis]
14 Garabedian MJ, Logan SK. Atypical regulation of SRC-3. Trends in Biochemical Sciences 2008;33:301-4. [DOI: 10.1016/j.tibs.2008.04.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
15 Voisin V, Legault P, Ospina DP, Ben-David Y, Rassart E. Gene profiling of the erythro- and megakaryoblastic leukaemias induced by the Graffi murine retrovirus. BMC Med Genomics 2010;3:2. [PMID: 20102610 DOI: 10.1186/1755-8794-3-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
16 McCafferty MP, McNeill RE, Miller N, Kerin MJ. Interactions between the estrogen receptor, its cofactors and microRNAs in breast cancer. Breast Cancer Res Treat. 2009;116:425-432. [PMID: 19507020 DOI: 10.1007/s10549-009-0429-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
17 Alvarado CV, Rubio MF, Fernández Larrosa PN, Panelo LC, Azurmendi PJ, Ruiz Grecco M, Martínez-Nöel GA, Costas MA. The levels of RAC3 expression are up regulated by TNF in the inflammatory response. FEBS Open Bio 2014;4:450-7. [PMID: 24918060 DOI: 10.1016/j.fob.2014.04.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
18 Turkel N, Sahota VK, Bolden JE, Goulding KR, Doggett K, Willoughby LF, Blanco E, Martin-Blanco E, Corominas M, Ellul J, Aigaki T, Richardson HE, Brumby AM. The BTB-zinc finger transcription factor abrupt acts as an epithelial oncogene in Drosophila melanogaster through maintaining a progenitor-like cell state. PLoS Genet 2013;9:e1003627. [PMID: 23874226 DOI: 10.1371/journal.pgen.1003627] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
19 Burandt E, Jens G, Holst F, Jänicke F, Müller V, Quaas A, Choschzick M, Wilczak W, Terracciano L, Simon R, Sauter G, Lebeau A. Prognostic relevance of AIB1 (NCoA3) amplification and overexpression in breast cancer. Breast Cancer Res Treat 2013;137:745-53. [PMID: 23322234 DOI: 10.1007/s10549-013-2406-4] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 3.6] [Reference Citation Analysis]
20 Reddy JK, Guo D, Jia Y, Yu S, Rao MS. Nuclear receptor transcriptional coactivators in development and metabolism. Nuclear Receptors in Development. Elsevier; 2006. pp. 389-420. [DOI: 10.1016/s1574-3349(06)16012-3] [Cited by in Crossref: 9] [Article Influence: 0.6] [Reference Citation Analysis]
21 Grivas PD, Tzelepi V, Sotiropoulou-Bonikou G, Kefalopoulou Z, Papavassiliou AG, Kalofonos H. Estrogen receptor alpha/beta, AIB1, and TIF2 in colorectal carcinogenesis: do coregulators have prognostic significance? Int J Colorectal Dis. 2009;24:613-622. [PMID: 19198856 DOI: 10.1007/s00384-009-0647-9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
22 Rueff J, Rodrigues AS. Cancer Drug Resistance: A Brief Overview from a Genetic Viewpoint. Methods Mol Biol 2016;1395:1-18. [PMID: 26910065 DOI: 10.1007/978-1-4939-3347-1_1] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 7.5] [Reference Citation Analysis]
23 Elkhadragy L, Alsaran H, Morel M, Long W. Activation loop phosphorylation of ERK3 is important for its kinase activity and ability to promote lung cancer cell invasiveness. J Biol Chem 2018;293:16193-205. [PMID: 30166347 DOI: 10.1074/jbc.RA118.003699] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
24 Chang AK, Wu H. The role of AIB1 in breast cancer. Oncol Lett 2012;4:588-94. [PMID: 23226788 DOI: 10.3892/ol.2012.803] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
25 Liu Y, Tong Z, Li T, Chen Q, Zhuo L, Li W, Wu RC, Yu C. Hepatitis B virus X protein stabilizes amplified in breast cancer 1 protein and cooperates with it to promote human hepatocellular carcinoma cell invasiveness. Hepatology. 2012;56:1015-1024. [PMID: 22473901 DOI: 10.1002/hep.25751] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 3.8] [Reference Citation Analysis]
26 Zhao Z, Zhang X, Wen L, Yi S, Hu J, Ruan J, Zhao F, Cui G, Fang J, Chen Y. Steroid receptor coactivator-3 is a pivotal target of gambogic acid in B-cell Non-Hodgkin lymphoma and an inducer of histone H3 deacetylation. Eur J Pharmacol 2016;789:46-59. [PMID: 27370960 DOI: 10.1016/j.ejphar.2016.06.048] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
27 Lanz RB, Bulynko Y, Malovannaya A, Labhart P, Wang L, Li W, Qin J, Harper M, O'Malley BW. Global characterization of transcriptional impact of the SRC-3 coregulator. Mol Endocrinol 2010;24:859-72. [PMID: 20181721 DOI: 10.1210/me.2009-0499] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 3.3] [Reference Citation Analysis]
28 He LR, Liu MZ, Li BK, Rao HL, Deng HX, Guan XY, Zeng YX, Xie D. Overexpression of AIB1 predicts resistance to chemoradiotherapy and poor prognosis in patients with primary esophageal squamous cell carcinoma. Cancer Sci. 2009;100:1591-1596. [PMID: 19552757 DOI: 10.1111/j.1349-7006.2009.01224.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
29 Mo P, Zhou Q, Guan L, Wang Y, Wang W, Miao M, Tong Z, Li M, Majaz S, Liu Y. Amplified in breast cancer 1 promotes colorectal cancer progression through enhancing notch signaling. Oncogene. 2015;34:3935-3945. [PMID: 25263446 DOI: 10.1038/onc.2014.324] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
30 Gabrovska P, Smith R, O'leary G, Haupt L, Griffiths L. Investigation of the 1758G>C and 2880A>G variants within the NCOA3 gene in a breast cancer affected Australian population. Gene 2011;482:68-72. [DOI: 10.1016/j.gene.2011.05.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
31 Adams BD, Cowee DM, White BA. The role of miR-206 in the epidermal growth factor (EGF) induced repression of estrogen receptor-alpha (ERalpha) signaling and a luminal phenotype in MCF-7 breast cancer cells. Mol Endocrinol. 2009;23:1215-1230. [PMID: 19423651 DOI: 10.1210/me.2009-0062] [Cited by in Crossref: 74] [Cited by in F6Publishing: 75] [Article Influence: 5.7] [Reference Citation Analysis]
32 Li L, Bao J, Wang H, Lei JH, Peng C, Zeng J, Hao W, Zhang X, Xu X, Yu C, Deng CX, Chen Q. Upregulation of amplified in breast cancer 1 contributes to pancreatic ductal adenocarcinoma progression and vulnerability to blockage of hedgehog activation. Theranostics 2021;11:1672-89. [PMID: 33408774 DOI: 10.7150/thno.47390] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Chung AC, Zhou S, Liao L, Tien JC, Greenberg NM, Xu J. Genetic ablation of the amplified-in-breast cancer 1 inhibits spontaneous prostate cancer progression in mice. Cancer Res 2007;67:5965-75. [PMID: 17575167 DOI: 10.1158/0008-5472.CAN-06-3168] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 2.5] [Reference Citation Analysis]
34 Malovannaya A, Lanz RB, Jung SY, Bulynko Y, Le NT, Chan DW, Ding C, Shi Y, Yucer N, Krenciute G, Kim BJ, Li C, Chen R, Li W, Wang Y, O'Malley BW, Qin J. Analysis of the human endogenous coregulator complexome. Cell 2011;145:787-99. [PMID: 21620140 DOI: 10.1016/j.cell.2011.05.006] [Cited by in Crossref: 303] [Cited by in F6Publishing: 284] [Article Influence: 27.5] [Reference Citation Analysis]
35 Machado MS, Rosa FD, Lira MC, Urtreger AJ, Rubio MF, Costas MA. The inflammatory cytokine TNF contributes with RAC3-induced malignant transformation. EXCLI J 2018;17:1030-42. [PMID: 30585274 DOI: 10.17179/excli2018-1759] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
36 Lee WK, Cheng SY. Targeting transcriptional regulators for treatment of anaplastic thyroid cancer. J Cancer Metastasis Treat 2021;7:27. [PMID: 34761120 DOI: 10.20517/2394-4722.2021.58] [Reference Citation Analysis]
37 Xu FP, Liu YH, Luo XL, Zhang F, Zhou HY, Ge Y, Liu C, Chen J, Luo DL, Yan LX, Mei P, Xu J, Zhuang HG. Overexpression of SRC-3 promotes esophageal squamous cell carcinoma aggressiveness by enhancing cell growth and invasiveness. Cancer Med 2016;5:3500-11. [PMID: 27781415 DOI: 10.1002/cam4.884] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
38 Fernández Larrosa PN, Ruíz Grecco M, Mengual Gómez D, Alvarado CV, Panelo LC, Rubio MF, Alonso DF, Gómez DE, Costas MA. RAC3 more than a nuclear receptor coactivator: a key inhibitor of senescence that is downregulated in aging. Cell Death Dis 2015;6:e1902. [PMID: 26469953 DOI: 10.1038/cddis.2015.218] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
39 Yan J, Erdem H, Li R, Cai Y, Ayala G, Ittmann M, Yu-Lee LY, Tsai SY, Tsai MJ. Steroid receptor coactivator-3/AIB1 promotes cell migration and invasiveness through focal adhesion turnover and matrix metalloproteinase expression. Cancer Res 2008;68:5460-8. [PMID: 18593949 DOI: 10.1158/0008-5472.CAN-08-0955] [Cited by in Crossref: 79] [Cited by in F6Publishing: 57] [Article Influence: 5.6] [Reference Citation Analysis]
40 Shen L, Zhang F, Huang R, Yan J, Shen B. Honokiol inhibits bladder cancer cell invasion through repressing SRC-3 expression and epithelial-mesenchymal transition. Oncol Lett 2017;14:4294-300. [PMID: 28943942 DOI: 10.3892/ol.2017.6665] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
41 Huang X, Ma F, Zhang R, Dai X, Ren Q. Taiman negatively regulates the expression of antimicrobial peptides by promoting the transcription of cactus in Macrobrachium nipponense. Fish Shellfish Immunol 2020;105:152-63. [PMID: 32652297 DOI: 10.1016/j.fsi.2020.06.045] [Reference Citation Analysis]
42 Kefalopoulou Z, Tzelepi V, Zolota V, Grivas PD, Christopoulos C, Kalofonos H, Maraziotis T, Sotiropoulou-Bonikou G. Prognostic value of novel biomarkers in astrocytic brain tumors: nuclear receptor co-regulators AIB1, TIF2, and PELP1 are associated with high tumor grade and worse patient prognosis. J Neurooncol 2012;106:23-31. [PMID: 21735116 DOI: 10.1007/s11060-011-0637-y] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 2.6] [Reference Citation Analysis]
43 Zhang C, Robinson BS, Xu W, Yang L, Yao B, Zhao H, Byun PK, Jin P, Veraksa A, Moberg KH. The ecdysone receptor coactivator Taiman links Yorkie to transcriptional control of germline stem cell factors in somatic tissue. Dev Cell 2015;34:168-80. [PMID: 26143992 DOI: 10.1016/j.devcel.2015.05.010] [Cited by in Crossref: 44] [Cited by in F6Publishing: 34] [Article Influence: 6.3] [Reference Citation Analysis]
44 Mardilovich K, Pankratz SL, Shaw LM. Expression and function of the insulin receptor substrate proteins in cancer. Cell Commun Signal 2009;7:14. [PMID: 19534786 DOI: 10.1186/1478-811X-7-14] [Cited by in Crossref: 91] [Cited by in F6Publishing: 65] [Article Influence: 7.0] [Reference Citation Analysis]
45 Lee WK, Kim WG, Fozzatti L, Park S, Zhao L, Willingham MC, Lonard D, O'Malley BW, Cheng SY. Steroid receptor coactivator-3 as a target for anaplastic thyroid cancer. Endocr Relat Cancer 2020;27:209-20. [PMID: 31977311 DOI: 10.1530/ERC-19-0482] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
46 Conzen SD. Minireview: nuclear receptors and breast cancer. Mol Endocrinol. 2008;22:2215-2228. [PMID: 18417735 DOI: 10.1210/me.2007-0421] [Cited by in Crossref: 92] [Cited by in F6Publishing: 91] [Article Influence: 6.6] [Reference Citation Analysis]
47 An Y, Wu J, Yang B, Zhu Z, Gao M, Yu C, Yang CJ. Selection and Application of DNA Aptamer Against Oncogene Amplified in Breast Cancer 1. J Mol Evol 2015;81:179-85. [PMID: 26458993 DOI: 10.1007/s00239-015-9703-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
48 Jin J, Wang Y, Wang J, Xu Y, Chen S, Wang J, Ran X, Su Y. Increased radiosensitivity and radiation-induced apoptosis in SRC-3 knockout mice. J Radiat Res 2014;55:443-50. [PMID: 24309719 DOI: 10.1093/jrr/rrt132] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
49 Cai D, Shames DS, Raso MG, Xie Y, Kim YH, Pollack JR, Girard L, Sullivan JP, Gao B, Peyton M. Steroid receptor coactivator-3 expression in lung cancer and its role in the regulation of cancer cell survival and proliferation. Cancer Res. 2010;70:6477-6485. [PMID: 20663904 DOI: 10.1158/0008-5472.can-10-0005] [Cited by in Crossref: 47] [Cited by in F6Publishing: 30] [Article Influence: 3.9] [Reference Citation Analysis]
50 Wang H, Zhang D, Wu W, Zhang J, Guo D, Wang Q, Jing T, Xu C, Bian X, Yang K. Overexpression and gender-specific differences of SRC-3 (SRC-3/AIB1) immunoreactivity in human non-small cell lung cancer: an in vivo study. J Histochem Cytochem 2010;58:1121-7. [PMID: 20852035 DOI: 10.1369/jhc.2010.956979] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
51 Liu J, Xie Y, Guo J, Li X, Wang J, Jiang H, Peng Z, Wang J, Wang S, Li Q, Ye L, Zhong Y, Zhang Q, Liu X, Lonard DM, Wang J, O'Malley BW, Liu Z. Targeting NSD2-mediated SRC-3 liquid-liquid phase separation sensitizes bortezomib treatment in multiple myeloma. Nat Commun 2021;12:1022. [PMID: 33589584 DOI: 10.1038/s41467-021-21386-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
52 Ayala G, Yan J, Li R, Ding Y, Thompson TC, Mims MP, Hayes TG, MacDonnell V, Lynch RG, Frolov A. Bortezomib-mediated inhibition of steroid receptor coactivator-3 degradation leads to activated Akt. Clin Cancer Res. 2008;14:7511-7518. [PMID: 19010869 DOI: 10.1158/1078-0432.CCR-08-0839] [Cited by in Crossref: 24] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
53 Chen Q, Li W, Wan Y, Xia X, Wu Q, Chen Y, Lai Z, Yu C, Li W. Amplified in breast cancer 1 enhances human cholangiocarcinoma growth and chemoresistance by simultaneous activation of Akt and Nrf2 pathways. Hepatology 2012;55:1820-9. [PMID: 22213475 DOI: 10.1002/hep.25549] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 4.6] [Reference Citation Analysis]
54 Koorstra JB, Hustinx SR, Offerhaus GJ, Maitra A. Pancreatic carcinogenesis. Pancreatology. 2008;8:110-125. [PMID: 18382097 DOI: 10.1159/000123838] [Cited by in Crossref: 126] [Cited by in F6Publishing: 125] [Article Influence: 9.0] [Reference Citation Analysis]
55 Jang AC, Chang YC, Bai J, Montell D. Border-cell migration requires integration of spatial and temporal signals by the BTB protein Abrupt. Nat Cell Biol 2009;11:569-79. [PMID: 19350016 DOI: 10.1038/ncb1863] [Cited by in Crossref: 77] [Cited by in F6Publishing: 67] [Article Influence: 5.9] [Reference Citation Analysis]
56 Zhao W, Chang C, Cui Y, Zhao X, Yang J, Shen L, Zhou J, Hou Z, Zhang Z, Ye C, Hasenmayer D, Perkins R, Huang X, Yao X, Yu L, Huang R, Zhang D, Guo H, Yan J. Steroid receptor coactivator-3 regulates glucose metabolism in bladder cancer cells through coactivation of hypoxia inducible factor 1α. J Biol Chem 2014;289:11219-29. [PMID: 24584933 DOI: 10.1074/jbc.M113.535989] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 3.5] [Reference Citation Analysis]
57 Panelo LC, Machado MS, Rubio MF, Jaworski F, Alvarado CV, Paz LA, Urtreger AJ, Vazquez E, Costas MA. High RAC3 expression levels are required for induction and maintaining of cancer cell stemness. Oncotarget 2018;9:5848-60. [PMID: 29464039 DOI: 10.18632/oncotarget.23635] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
58 Sun Q, Yang J, Xing G, Sun Q, Zhang L, He F. Expression of GSDML Associates with Tumor Progression in Uterine Cervix Cancer. Transl Oncol 2008;1:73-83. [PMID: 18633457 DOI: 10.1593/tlo.08112] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 3.5] [Reference Citation Analysis]
59 Li Z, Fang ZY, Ding Y, Yao WT, Yang Y, Zhu ZQ, Wang W, Zhang QX. Amplifications of NCOA3 gene in colorectal cancers in a Chinese population. World J Gastroenterol 2012; 18(8): 855-860 [PMID: 22371647 DOI: 10.3748/wjg.v18.i8.855] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
60 Colo GP, Rubio MF, Nojek IM, Werbajh SE, Echeverría PC, Alvarado CV, Nahmod VE, Galigniana MD, Costas MA. The p160 nuclear receptor co-activator RAC3 exerts an anti-apoptotic role through a cytoplasmatic action. Oncogene 2008;27:2430-44. [DOI: 10.1038/sj.onc.1210900] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 2.8] [Reference Citation Analysis]
61 Kleibl Z, Havranek O, Kormunda S, Novotny J, Foretova L, Machackova E, Soukupova J, Janatova M, Tavandzis S, Pohlreich P. The AIB1 gene polyglutamine repeat length polymorphism and the risk of breast cancer development. J Cancer Res Clin Oncol 2011;137:331-8. [PMID: 20422428 DOI: 10.1007/s00432-010-0889-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
62 Jin J, Cheng S, Wang Y, Wang T, Zeng D, Li Z, Li X, Wang J. SRC3 expressed in bone marrow mesenchymal stem cells promotes the development of multiple myeloma. Acta Biochim Biophys Sin (Shanghai) 2019;51:1258-66. [PMID: 31769473 DOI: 10.1093/abbs/gmz130] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
63 Xiao H, Liu J, He J, Lan Z, Deng M, Hu Z. 17β-Estradiol Attenuates Intracerebral Hemorrhage-Induced Blood-Brain Barrier Injury and Oxidative Stress Through SRC3-Mediated PI3K/Akt Signaling Pathway in a Mouse Model. ASN Neuro 2021;13:17590914211038443. [PMID: 34491125 DOI: 10.1177/17590914211038443] [Reference Citation Analysis]
64 Gilad Y, Eliaz Y, Yu Y, Dean AM, Han SJ, Qin L, O'Malley BW, Lonard DM. A genome-scale CRISPR Cas9 dropout screen identifies synthetically lethal targets in SRC-3 inhibited cancer cells. Commun Biol 2021;4:399. [PMID: 33767353 DOI: 10.1038/s42003-021-01929-1] [Reference Citation Analysis]
65 He L, Deng H, Liu S, Chen J, Li B, Wang C, Wang X, Jiang Y, Ma N, Liu M, Xie D. Overexpression of amplified in breast cancer 1 (AIB1) gene promotes lung adenocarcinoma aggressiveness in vitro and in vivo by upregulating C-X-C motif chemokine receptor 4. Cancer Commun (Lond) 2018;38:53. [PMID: 30103827 DOI: 10.1186/s40880-018-0320-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
66 Liu W, Sun L, Zhang J, Song W, Li M, Wang H. The landscape and prognostic value of immune characteristics in uterine corpus endometrial cancer. Biosci Rep 2021;41:BSR20202321. [PMID: 33782686 DOI: 10.1042/BSR20202321] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
67 Ying H, Willingham MC, Cheng SY. The steroid receptor coactivator-3 is a tumor promoter in a mouse model of thyroid cancer. Oncogene 2008;27:823-30. [PMID: 17653082 DOI: 10.1038/sj.onc.1210680] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.3] [Reference Citation Analysis]